Erratum: “Long‐term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinura” by Hillmen et al., Am J Hematol 553–559, 2010, DOI number 21757

Abstract

In the above mentioned article, several errors occurred and are corrected below. In the labeling of Figure 1, page 555. The term “Eculizumab Treatment” should not appear at the top of the figure. The corrected figure is shown. On page 553 in the Abstract line 6, “Renal dysfunction or damage was observed in 65% of the study population…” should read “Renal dysfunction or damage was observed in 64% of the study population….” On page 555 line 2, “Renal dysfunction or damage was a common finding in patients with PNH as 65% of the study population … .” Should read “Renal dysfunction or damage was a common finding in patients with PNH as 64% of the study population … .” On page 557 line 5, “Because of the recognized high incidence (65%) of renal dysfunction… .” Should read “Because of the recognized high incidence (64%) of renal dysfunction… .” We apologize for any confusion these errors might have caused.